Vigonvita Life Sciences : April 2026 Monthly Return Shows Unchanged Share Base and Full Public Float Compliance

Bulletin Express05-07 06:43

Vigonvita Life Sciences Co., Ltd. submitted its monthly return for the period ended 30 April 2026, confirming a stable capital structure and adherence to Hong Kong Listing Rule public-float requirements.

Authorised and Issued Share Capital • Total authorised share capital stood at RMB 167.60 million, unchanged from the prior month. • This comprises 66.68 million H-shares listed on the Stock Exchange of Hong Kong and 100.92 million unlisted ordinary shares, each carrying a par value of RMB 1. • Issued shares mirrored authorised figures, with no share issuances, cancellations, or treasury share movements recorded during the month.

Public Float Status • The company affirmed that its H-share public float met the minimum 25 % threshold mandated by Main Board Rule 13.32B.

Capital Instruments and Corporate Actions • No share options, warrants, convertible securities, or other equity-linked instruments were outstanding or issued. • There were no repurchases, redemptions, or other alterations to share capital.

Regulatory Compliance • The filing, dated 07 May 2026 and signed by Board Secretary Guo Ting, includes standard confirmations that all listing, legal and regulatory obligations have been fulfilled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165772726?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 06:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165772726","market":"us","top_or_hot":-1,"title":"Vigonvita Life Sciences : April 2026 Monthly Return Shows Unchanged Share Base and Full Public Float Compliance","media":"Bulletin Express","content":"<p>Vigonvita Life Sciences Co., Ltd. submitted its monthly return for the period ended 30 April 2026, confirming a stable capital structure and adherence to Hong Kong Listing Rule public-float requirements.</p>\n<p>Authorised and Issued Share Capital  \n• Total authorised share capital stood at RMB 167.60 million, unchanged from the prior month.  \n• This comprises 66.68 million H-shares listed on the Stock Exchange of Hong Kong and 100.92 million unlisted ordinary shares, each carrying a par value of RMB 1.  \n• Issued shares mirrored authorised figures, with no share issuances, cancellations, or treasury share movements recorded during the month.</p>\n<p>Public Float Status  \n• The company affirmed that its H-share public float met the minimum 25 % threshold mandated by Main Board Rule 13.32B.</p>\n<p>Capital Instruments and Corporate Actions  \n• No share options, warrants, convertible securities, or other equity-linked instruments were outstanding or issued.  \n• There were no repurchases, redemptions, or other alterations to share capital.</p>\n<p>Regulatory Compliance  \n• The filing, dated 07 May 2026 and signed by Board Secretary Guo Ting, includes standard confirmations that all listing, legal and regulatory obligations have been fulfilled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vigonvita Life Sciences : April 2026 Monthly Return Shows Unchanged Share Base and Full Public Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVigonvita Life Sciences : April 2026 Monthly Return Shows Unchanged Share Base and Full Public Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-07 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vigonvita Life Sciences Co., Ltd. submitted its monthly return for the period ended 30 April 2026, confirming a stable capital structure and adherence to Hong Kong Listing Rule public-float requirements.</p>\n<p>Authorised and Issued Share Capital  \n• Total authorised share capital stood at RMB 167.60 million, unchanged from the prior month.  \n• This comprises 66.68 million H-shares listed on the Stock Exchange of Hong Kong and 100.92 million unlisted ordinary shares, each carrying a par value of RMB 1.  \n• Issued shares mirrored authorised figures, with no share issuances, cancellations, or treasury share movements recorded during the month.</p>\n<p>Public Float Status  \n• The company affirmed that its H-share public float met the minimum 25 % threshold mandated by Main Board Rule 13.32B.</p>\n<p>Capital Instruments and Corporate Actions  \n• No share options, warrants, convertible securities, or other equity-linked instruments were outstanding or issued.  \n• There were no repurchases, redemptions, or other alterations to share capital.</p>\n<p>Regulatory Compliance  \n• The filing, dated 07 May 2026 and signed by Board Secretary Guo Ting, includes standard confirmations that all listing, legal and regulatory obligations have been fulfilled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02630","symbol_name":"旺山旺水-B","start_time":0,"source_url":"","article_id":"1165772726","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165772726","pubTimestamp":1778107399,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vigonvita Life Sciences Co., Ltd. submitted its monthly return for the period ended 30 April 2026, confirming a stable capital structure and adherence to Hong Kong Listing Rule public-float...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02630":"旺山旺水-B"},"translate_title":"Vigonvita Life Sciences：2026年4月月度报告显示股份基础不变且公众持股量完全合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02630":1},"content_text":"Vigonvita Life Sciences Co., Ltd. submitted its monthly return for the period ended 30 April 2026, confirming a stable capital structure and adherence to Hong Kong Listing Rule public-float requirements.\nAuthorised and Issued Share Capital  \n• Total authorised share capital stood at RMB 167.60 million, unchanged from the prior month.  \n• This comprises 66.68 million H-shares listed on the Stock Exchange of Hong Kong and 100.92 million unlisted ordinary shares, each carrying a par value of RMB 1.  \n• Issued shares mirrored authorised figures, with no share issuances, cancellations, or treasury share movements recorded during the month.\nPublic Float Status  \n• The company affirmed that its H-share public float met the minimum 25 % threshold mandated by Main Board Rule 13.32B.\nCapital Instruments and Corporate Actions  \n• No share options, warrants, convertible securities, or other equity-linked instruments were outstanding or issued.  \n• There were no repurchases, redemptions, or other alterations to share capital.\nRegulatory Compliance  \n• The filing, dated 07 May 2026 and signed by Board Secretary Guo Ting, includes standard confirmations that all listing, legal and regulatory obligations have been fulfilled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165772726","isCrawlerRequest":true}